Duopharma Biotech Berhad

Rachunek Zysków i Strat kwartalnie


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna


2014-092014-122015-032015-062015-092015-122016-032016-062016-092016-122017-032017-062017-092017-122018-032018-062018-092018-122019-032019-062019-092019-122020-032020-062020-092020-122021-032021-062021-092021-122022-032022-062022-092022-122023-032023-062023-092023-122024-032024-06050M100M150M200M0.050.10.150.20.25
PrzychódZysk nettoEBIT %PrzychódEBIT (%)

index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39
Rok finansowy 2014 2014 2015 2015 2015 2015 2016 2016 2016 2016 2017 2017 2017 2017 2018 2018 2018 2018 2019 2019 2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024
Data 2014-09-30 2014-12-31 2015-03-31 2015-06-30 2015-09-30 2015-12-31 2016-03-31 2016-06-30 2016-09-30 2016-12-31 2017-03-31 2017-06-30 2017-09-30 2017-12-31 2018-03-31 2018-06-30 2018-09-30 2018-12-31 2019-03-31 2019-06-30 2019-09-30 2019-12-31 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30
Kwartał Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2
Przychód (mln) 45 51 46 56 79 89 79 79 80 74 123 117 115 112 133 124 126 116 150 145 143 138 159 143 134 134 166 155 172 145 186 182 177 152 200 168 169 168 193 218
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 77.1% 73.5% 74.3% 40.5% 1.2% <span style="color:red">-16.36%</span> 55.2% 47.9% 43.7% 51.6% 8.1% 5.9% 9.1% 3.0% 12.9% 17.3% 13.5% 19.1% 5.5% <span style="color:red">-1.47%</span> <span style="color:red">-6.36%</span> <span style="color:red">-2.66%</span> 4.9% 8.4% 28.5% 8.5% 11.7% 16.9% 3.0% 4.5% 7.8% <span style="color:red">-7.83%</span> <span style="color:red">-4.43%</span> 10.2% <span style="color:red">-3.74%</span> 30.3%
Marża brutto 46.7% 45.9% 51.6% 42.9% 51.3% 45.8% 45.6% 45.3% 44.8% 48.7% 36.2% 42.4% 44.1% 37.2% 39.5% 42.2% 39.5% 43.1% 39.1% 43.0% 41.0% 37.9% 42.1% 38.9% 40.0% 42.6% 40.7% 39.0% 39.1% 40.2% 40.8% 37.9% 40.8% 41.3% 41.2% 39.3% 38.1% 33.1% 38.5% 34.3%
Koszty i Wydatki (mln) 33 37 33 48 66 72 69 71 73 67 111 104 100 100 119 110 108 97 131 124 122 125 140 122 114 113 142 133 148 128 158 158 152 136 170 147 153 157 167 191
EBIT (mln) 11 14 12 9 13 16 10 8 8 7 13 13 15 13 14 14 18 19 21 22 21 14 19 22 20 21 25 22 24 18 28 24 25 17 30 21 17 10 26 27
EBIT Δ kw/kw 12.4% 14.9% 19.3% 5.6% 70.8% 139.8% 19.9% 39.2% 49.4% 48.0% 10.8% 6.2% 14.1% 31.5% 33.1% 34.2% 14.6% 36.1% 11.9% 0.2% 2.6% 33.3% 22.4% 3.7% 17.1% 20.2% 12.1% 5.1% 2.6% 6.6% 8.0% 14.8% 48.3% 62.3% 14.8% 24.5% 0.0% 0.0% 0.0% 0.0%
EBIT (%) 25.4% 27.4% 26.7% 15.3% 16.4% 18.6% 12.8% 10.3% 9.5% 9.2% 10.3% 11.4% 13.0% 11.7% 10.7% 11.5% 13.9% 16.6% 14.2% 14.9% 14.4% 10.3% 12.0% 15.1% 14.9% 15.8% 14.8% 14.5% 14.0% 12.1% 15.0% 13.0% 14.0% 10.9% 15.1% 12.3% 9.9% 6.1% 13.7% 12.5%
Przychody fiansowe (mln) 0 0 0 0 1 1 1 1 1 1 1 1 0 1 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 2 1
Koszty finansowe (mln) 0 0 0 0 2 1 1 1 1 1 1 1 1 1 1 2 2 2 3 4 1 1 2 3 2 0 2 3 2 0 2 3 4 1 3 5 6 5 7 7
Amortyzacja (mln) 2 2 2 3 11 6 6 6 6 6 5 6 8 5 5 6 6 8 6 6 6 9 7 7 7 8 8 8 8 8 8 8 8 9 10 9 9 14 11 11
EBITDA (mln) 13 16 14 12 24 23 17 15 14 13 19 20 23 19 20 21 23 28 27 28 27 24 26 29 27 29 33 30 33 26 37 32 34 28 40 30 27 24 38 39
EBITDA(%) 30.0% 31.4% 31.5% 21.0% 30.5% 25.4% 21.3% 18.6% 17.9% 18.0% 15.3% 17.0% 19.9% 17.1% 15.2% 16.6% 18.6% 24.0% 18.0% 19.3% 18.9% 17.1% 16.4% 20.3% 20.4% 21.8% 19.6% 19.5% 19.0% 17.6% 19.7% 17.8% 19.0% 18.2% 20.1% 18.2% 16.2% 14.6% 19.6% 17.7%
NOPLAT (mln) 11 14 12 8 12 16 10 8 8 6 12 13 14 13 13 13 16 18 19 18 20 14 18 19 19 20 23 20 22 17 27 21 21 15 28 17 11 7 20 22
Podatek (mln) 3 3 3 3 3 3 2 4 1 -3 3 3 3 1 3 3 4 3 4 4 5 2 4 5 4 4 6 5 6 1 6 5 5 -2 6 4 2 -1 5 5
Zysk Netto (mln) 9 11 9 6 9 13 8 4 6 9 10 10 11 12 11 10 12 14 14 14 15 12 14 15 14 16 18 15 17 16 20 16 16 17 23 13 9 9 15 17
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% <span style="color:red">-0.68%</span> 21.0% <span style="color:red">-12.72%</span> <span style="color:red">-32.61%</span> <span style="color:red">-27.80%</span> <span style="color:red">-31.81%</span> 22.2% 144.6% 78.7% 37.4% 11.3% 7.2% 10.4% 18.4% 35.9% 34.6% 20.9% <span style="color:red">-16.26%</span> <span style="color:red">-6.25%</span> 5.8% <span style="color:red">-4.93%</span> 34.6% 29.9% 4.5% 20.1% <span style="color:red">-2.95%</span> 15.2% 6.0% <span style="color:red">-3.62%</span> 9.2% 11.5% <span style="color:red">-23.11%</span> <span style="color:red">-45.13%</span> <span style="color:red">-50.46%</span> <span style="color:red">-32.50%</span> 33.1%
Zysk netto (%) 19.4% 21.0% 19.7% 10.4% 10.9% 14.6% 9.9% 5.0% 7.8% 11.9% 7.8% 8.2% 9.6% 10.8% 8.0% 8.3% 9.8% 12.4% 9.6% 9.6% 10.4% 8.7% 8.5% 10.3% 10.6% 12.1% 10.6% 9.9% 9.9% 10.8% 10.9% 9.0% 9.2% 11.3% 11.3% 7.5% 5.3% 5.1% 7.9% 7.6%
EPS 0.0201 0.018 0.0207 0.0135 0.0167 0.015 0.009 0.0045 0.0072 0.01 0.011 0.026 0.0128 0.014 0.0123 0.0119 0.014 0.016 0.0164 0.0155 0.0165 0.013 0.0149 0.0161 0.0152 0.017 0.019 0.0163 0.018 0.0169 0.0219 0.0172 0.0172 0.018 0.0238 0.0131 0.0093 0.0088 0.0159 0.0174
EPS (rozwodnione) 0.0201 0.018 0.0207 0.0135 0.0167 0.015 0.009 0.0045 0.0072 0.01 0.011 0.026 0.0128 0.014 0.0123 0.0119 0.014 0.016 0.0164 0.0155 0.0165 0.013 0.0149 0.0161 0.0152 0.017 0.019 0.0163 0.018 0.0169 0.0219 0.0172 0.0172 0.018 0.0238 0.0131 0.0093 0.0088 0.0159 0.0174
Ilośc akcji (mln) 432 583 434 434 868 868 867 870 869 868 868 372 868 868 866 867 881 883 881 896 901 909 913 913 931 941 927 942 942 890 928 947 951 952 952 958 962 962 962 962
Ważona ilośc akcji (mln) 432 585 434 434 868 868 867 870 869 868 868 372 868 868 866 867 881 883 881 896 901 913 913 913 931 941 927 944 942 928 928 947 952 952 952 958 962 962 962 962
Waluta MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR MYR